Skip to content

INFLUENCE OF LIDOCAINE UPON CELLULAR COAGULATION: IN VITRO INVESTIGATIONS USING THE MULTI-PLATE® THROMBOCYTE AGGREGOMETER

INFLUENCE OF LIDOCAINE UPON CELLULAR COAGULATION: IN VITRO INVESTIGATIONS USING THE MULTI-PLATE® THROMBOCYTE AGGREGOMETER - Lidocaine and MultiPlate in vitro

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35331
Enrollment
10
Registered
2012-02-01
Start date
2012-07-05
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coagulation Thrombocyte function

Interventions

The only intervention in volunteers is the drawing of 12 ml of whole blood via venipuncture. Intervention will take place in vitro: Incubation will be performed with lidocaine at concentrations betw

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers, aged 18-65, ASA status I.

Exclusion criteria

Exclusion criteria: History of abnormal bleeding, ingestion of coagulation imparing drugs, pre-existing disease of heart, lungs, vessels, kidneys or liver.

Design outcomes

Primary

MeasureTime frame
The main study parameter is thrombocyte aggregation in vitro in the ASPItest of MultiPlate, expressed as Area under the Curve (AUC).

Secondary

MeasureTime frame
Secondary objectives of the study are results from three other complementary tests using MultiPlate, i.e. the TRAPtest and COLtest, which both test the potential of activation of thrombocytes, and the ADP-test, which tests for thrombocyte impairment via the ADP pathway (e.g., clopidogrel).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)